The effect of glucose-insulin-potassium treatment on myocardial oxidative stress in patients with acute coronary syndromes undergoing percutaneous coronary intervention

Coronary Artery Disease

Volumn 19, Issue 2, 2008, Pages 99-104

  Demircan, Sabri ^a   Yazici, Mustafa ^a   Diraman, Emine ^a   Demircan, Gunnur ^a   Kilicaslan, Fethi ^b   Durna, Kenan ^a   Acar, Zeydin ^a   Eren, Zafer ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Acute coronary syndromes; Coronary intervention; Glucose insulin potassium treatment; Oxidative stress

Indexed keywords

CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE; INSULIN; POTASSIUM; SUPEROXIDE DISMUTASE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; FEMORAL VEIN; HEART HEMODYNAMICS; HUMAN; MALE; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOPLEGIC SOLUTIONS; CATALASE; FEMALE; GLUCOSE; GLUTATHIONE PEROXIDASE; HUMANS; INSULIN; LACTIC ACID; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; POTASSIUM; SODIUM CHLORIDE; STENTS; SUPEROXIDE DISMUTASE;

EID: 39849083603     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3282f27c34     Document Type: Article

References (51)

1. Hearse DJ. Ischemia, reperfusion, and the determinants of tissue injury. Cardiovasc Drugs Ther 1990; 4:767-776.
2. Garlick PB, Davies MJ, Hearse DJ, Slater TF. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987; 61:757-760.
3. West NEJ, Guzik TJ, Black E, Channon KM. Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 2001; 21:189-194.
4. Demircan G, Diraman E, Demircan S. The importance of oxidative stress in heart diseases. Arch Turk Soc Cardiol 2005; 33:488-492.
5. Whitlow PL, Rogers WJ, Smith LG, McDaniel HG, Papapietro SE, Mantle JA, et al. Enhancement of left ventricular function by glucose-insulin- potassium infusion in acute myocardial infarction. Am J Cardiol 1982; 49:811-820.
6. Khoury VK, Haluska B, Prins J, Marwick TH. Effects of glucose-insulin-potassium infusion on chronic ischemic left ventricular dysfunction. Heart 2003; 89:61-65.
7. Cottin Y, Lhuillier I, Zeller M, Bonnett C, Toulousse C, Louis P, et al. Glucose insulin potassium improves systolic function in patients with chronic ischemic cardiomyopathy. Eur J Heart Fail 2002; 4:181-184.
8. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute infarction: an overview of randomized placebo-controlled trials. Circulation 1997; 96:1152-1156.
9. La Vecchia L, Bedogni F, Finocchi G, Mezzena G, Martini M, Sartori M, et al. Troponin-I and creatine kinase-MB mass after elective coronary stenting. Coron Artery Dis 1996; 7:535-540.
10. Bertinchant JP, Polge A, Ledermann B, Genet L, Fabbro-Peray P, Raczka F, et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 1999; 84:51-57.
11. Yazici M, Demircan S, Durna K, Yasar E, Acar Z, Sahin M. Effect of glucose-insulin-potassium infusion on myocardial damage due to percutaneous coronary revascularization. Am J Cardiol 2005; 96:1517-1520.
12. Guemouri L, Artur Y, Herbeth B, Jeandel C, Cuny G, Siest G. Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 1991; 37:1932-1937.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
14. Lück H. Catalase. In: Bergmeyer HU, ed. Methods of enzymatic analysis. 2nd ed. Verlag Chemie New York: Weinheim and Academic Pres; 1963. pp. 885-888.
15. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244:6049-6055.
16. Flohe L, Otting F. Superoxide dismutase assays. Methods Enzymol 1984; 105:93-104.
17. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976; 71:952-958.
18. Iuliano L, Pratico D, Greco C, Mangieri E, Scibilia G, FitzGerald GA, et al. Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol 2001; 37:76-80.
19. Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A, et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 2004; 109:3164-3170.
20. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990; 344:1160-1162.
21. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992; 70:593-599.
22. Ku G, Doherty NS, Wolos JA, Jackson RL. Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis. Am J Cardiol 1988; 62:77B-81B.
23. Imai K, Matsubara T, Kanashiro M, Ichimiya S, Hotta N. Lipid peroxidation may predict restenosis after coronary balloon angioplasty. Jpn Circ J 2001; 65:495-499.
24. Yokoi H, Daida H, Kuwabara Y, Nishikawa H, Takatsu F, Tomihara H, et al. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the probucol angioplasty restenosis trial. J Am Coll Cardiol 1997; 30:855-862.
25. DeMaio SJ, King SB III, Lembo NJ, Roubin GS, Hearn JA, Bhagavan HN, et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr 1992; 11:68-73.
26. Cicek D, Tamer L, Pekdemir H, Cin VG, Yildirim H, Kara AA, Yurtdas M. Coronary angioplasty induced oxidative stress and its relation with metoprolol use and plasma homocysteine levels. Anadolu Kardiyol Derg 2006; 6:308-313.
27. Sodi-Pallares D, Testelli MR, Fishleder BL, Bisteni A, Medrano GA, Friedland C, et al. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 1962; 9:166-181.
28. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J Jr, et al. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 1971; 43:67-82.
29. Rackley CE, Russell RO Jr, Rogers WJ, Mantle JA, McDaniel HG, Papapietro SE. Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction. Am Heart J 1981; 102:1038-1049.
30. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26:57-65
31. Quinn DW, Pagano D, Bonser RS, Rooney SJ, Graham TR, Wilson IC, et al.; Study Investigators. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thorac Cardiovasc Surg 2006; 131:34-42.
32. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001; 89:1191-1198.
33. Doenst T, Richwine RT, Bray MS, Goodwin GW, Frazier OH, Taegtmeyer H. Insulin improves functional and metabolic recovery of reperfused working rat heart. Ann Thorac Surg 1999; 67:1682-1688.
34. Keating FK, Sobel BE, Schneider DJ. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. Am J Cardiol 2003; 92:1362-1365.
35. Worthley MI, Holmes AS, Willoughby SR, Kucia AM, Heresztyn T, Stewart S, et al. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration. J Am Coll Cardiol 2007; 49:304-310.
36. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26:650-661.
37. Cardillo C, Nambi SS, Kilcoyne CM, Choucair WK, Katz A, Quon MJ, et al. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999; 100:820-825.
38. Ren J, Walsh MF, Hamaty M, Sowers JR, Brown RA. Augmentation of the inotropic response to insulin in diabetic rat hearts. Life Sci 1999; 65:369-380.
39. Tune JD, Mallet RT, Downey HF. Insulin improves contractile function during moderate ischemia in canine left ventricle. Am J Physiol Heart Circ Physiol 1998; 274:H1574-H1581.
40. O'Brien RM, Granner DK. Regulation of gene expression by insulin. Biochem J 1991; 278:609-619.
41. Ferrara N, Abete P, Corbi G, Paolisso G, Longobardi G, Calabrese C, et al. Insulin-induced changes in [beta]-adrenergic response: an experimental study in the isolated rat papillary muscle. Am J Hypertens 2005; 18:348-353.
42. Von Lewinski D, Bruns S, Walther S, Kogler H, Pieske B. Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium. Circulation 2005; 111:2588-2595.
43. Ranasinghe AM, Quinn DW, Pagano D, Edwards N, Faroqui M, Graham TR, et al. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Circulation 2006; 114 (suppl I):I245-I250.
44. Yazici M, Demircan S, Aksakal E, Soylu K, Sahin M, Sagkan O. Effect of Glucose-insulin-potassium infusion on myocardial injury and endothelin-1 levels in chronic ischemic heart failure. Arch Turk Soc Cardiol 2004; 32:99-106.
45. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilatation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94:1172-1179.
46. Trovati M, Massacco P, Mattiello L, Mularoni E, Cavalot F, Anfossi G. Insulin increases guanosine-30,50-cyclic monophosphate in human platelets: a mechanism involved in the insulin anti-aggregating effect. Diabetes 1994; 43:1015-1019.
47. Díaz-Araya G, Nettle D, Castro P, Miranda F, Greig D, Campos X, et al. Oxidative stress after reperfusion with primary coronary angioplasty: lack of effect of glucose-insulin-potassium infusion. Crit Care Med 2002; 30:417-421.
48. Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res 1991; 68:466-481.
49. Sidossis LS, Stuart CA, Shulman GI, Lopaschuk GD, Wolfe RR. Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. J Clin Invest 1996; 98:2244-2250.
50. Savaskan D, Yurtseven N, Tuygun AK, Aksoy P, Canik S. The effects of insulin given prior to release of cross-clamp on coronary sinus lactate levels in coronary artery surgery. Anadolu Kardiyol Derg 2006; 6:248-252.
51. Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R, et al. Metabolic modulation of acute myocardial infarction: the ECLA glucose-insulin-potassium pilot trial. Circulation 1998; 98:2227-2234.